Page 20 - Who

Strengthen surveillance, public health measures for monkeypox: WHO

Regional Director of WHO's South-East Asia Region on Sunday called on member countries to strengthen surveillance and public health measures for monkeypox

White House calls for coordinated Int'l response to combat monkeypox

After World Health Organization (WHO) declared the MonkeyPox virus a public health emergency of international concern, White House said that coordinated international response is the need of the hour

Covid cases triple across Europe, hospitalisations double, says WHO

WHO's Europe director Dr Kluge said super-infectious relatives of omicron variant were driving new waves of disease across continent and that repeat infections could potentially lead to long Covid.

WHO's methodology for estimating Covid-19 deaths unscientific: Govt

India had objected to the 'one size fits all' approach adopted by the WHO as it might be true for smaller countries but cannot be applied to a huge and diverse country like India

Efforts needed to get routine immunisation back to pre-Covid times: WHO

Many counties have demonstrated that routine immunization can be maintained or scaled up along with COVID-19 vaccination, said Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia.

25 million children missed out on one or more doses of DTP vaccines: UN

Data by the World Health Organisation and UNICEF recorded the largest sustained decline in global childhood vaccinations in approximately 30 years

No need to panic over monkeypox, have taken steps to curb it: Kerala govt

3,413 cases reported till June-end across the world, with only one death

India, 4 others report least DTP vaccines given to children in 2021: UN

Data by the World Health Organisation and UNICEF recorded the largest sustained decline in global childhood vaccinations in approximately 30 years.

WHO chief warns of rising infections, deaths from new Covid wave

Europe is at the centre of a new wave of cases driven by the BA.4 and BA.5 omicron sub-variants as people attend large gatherings and resume traveling after two years of staying close to home

Monkeypox: WHO reports 5,322 lab-confirmed cases in 53 countries

Of these, 85% are in Europe, followed by the African region, the Americas, the Eastern Mediterranean and the Pacific, says WHO

Oxford University shifts focus to health threat triggering future pandemics

Oxford said the organization will seek to learn from the response to Covid and take advantage of the university's research and global partnerships

WHO urges Southeast Asia to scale up Covid vaccination rate as case rise

"While scaling up vaccination coverage, it is also important how it is achieved," the Regional Director said.

India's first mRNA Covid vaccine will be priced competitively, says company

Gemcovac does not require sub-zero temperatures for storage and transport, unlike two other international doses

Covid cases on rise in 110 countries, driven by 2 Omicron sub-variants: WHO

The Centers for Disease Control and Prevention said this week that the fast-spreading Omicron sub-variants BA.4 and BA.5 together are estimated to make up half of the coronavirus cases in the US

WHO warns 'sustained transmission' of monkeypox risks vulnerable groups

The virus has now been identified in more than 50 new countries outside the countries in Africa where it is endemic

LIVE updates: AAP leads over BJP by 10,000 votes in Rajinder Nagar bypoll

AAP candidate Durgesh Pathak surged ahead with a margin of over 10,000 votes over his immediate rival. Stay tuned for more

Monkeypox not a global emergency 'at this stage', says WHO panel

The World Health Organization said the escalating monkeypox outbreak in more than 50 countries should be closely monitored but does not warrant being declared a global health emergency

WHO considers declaring monkeypox a global health emergency

Declaring monkeypox to be a global emergency would mean the U.N. health agency considers the outbreak to be an extraordinary event and that the disease is at risk of spreading across even more borders

Biological E gets WHO nod to be addl facility for production of J&J vaccine

Biological E has received the WHO nod to be an additional facility for production of Johnson & Johnson COVID-19 vaccine. "Congratulations to @biological_e on its @WHO approval as an additional manufacturing site for the Janssen/Johnson & Johnson COVID-19 vaccine! Great progress for the Quad Vaccine and #USIndiaHealth partnerships through U.S. technical support and @DFCgov financing," the US embassy in India said in a tweet on Wednesday. India's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age group of 12 to 14 years. The Drugs Controller General of India (DCGI) recently approved Corbevax as a precaution dose for those aged 18 and above.

Trajectory of a killer disease

Vidya Krishnan been on the health beat for many years and meticulously documented weaknesses in global and Indian health policy, which have turned it into an unacknowledged pandemic